Safeway Seeks to Dissolve Secret $350 Million Deal With Beleaguered Blood Startup Theranos The partnership, code-named project 'T-Rex,' called for Theranos blood test facilities to be built in 800 Safeway stores nationwide.

By Geoff Weiss

Opinions expressed by Entrepreneur contributors are their own.

ceiling

The Theranos walls keep tumbling down.

Yet another exposé by Wall Street Journal reporter John Carreyrou last night revealed that the beleaguered blood test startup is severing ties with California-based supermarket chain Safeway. The two had inked a deal roughly five years ago codenamed project "T-Rex," in which Safeway paid $350 million to build Theranos-anchored blood test clinics in more than 800 of its doors nationwide.

But today, as misgivings about Theranos' technology -- which purports to perform a full range of blood tests with a mere finger prick -- have reached a fever pitch, both parties are looking to dissolve the partnership, the Journal reports. As blood tests never began and the project has been inactive for more than a year, the clinics are currently being used for flu shots and other travel-related vaccines.

Related: Out For Blood: Theranos Orchestrates Bold PR Coup in the Face of Damning Allegations

While Theranos inked a partnership with Walgreens in 2013 (this partnership has also been put on pause until Theranos resolves its issues, Walgreens has said), the Safeway deal precedes this agreement as the blood startup's exclusive supermarket partner. Safeway also reportedly invested $10 million in Theranos.

On its website, Theranos called the Journal story "inaccurate, misleading and defamatory," adding that, "No amount of cynical and misleading news coverage will stop us from focusing on our mission and our goals."

There were reportedly warning signs at the outset of the deal, current and former Safeway executives told the Journal. When Theranos came to its headquarters to do blood tests on employees, for instance, one received a frighteningly high result that suggested the executive had prostate cancer. A retest by a traditional lab showed nothing abnormal.

Related: Theranos Founder Says the Company Will 'Absolutely' Get FDA Approval

Geoff Weiss

Former Staff Writer

Geoff Weiss is a former staff writer at Entrepreneur.com.

Editor's Pick

Related Topics

Data & Recovery

Save $899 on This Guest Wi-Fi Solution That Offers You Plenty of Perks

Get marketing info while offering Wi-Fi to guests and customers with this tool, now $599.99 for life.

Business News

'No One Is Important:' Senior Executives at 'Sports Illustrated' Publishing House Are Out of a Job Following AI Article Controversy

The owner of the magazine's publisher, The Area Group, claims the shakeup was unrelated to the recent scandal.

Starting a Business

7 Lessons I Learned From Selling a 6-Figure Blogging Business

Here are a few critical lessons from my experience building and selling a successful blogging business.

Side Hustle

He Launched His Creative Side Hustle Out of a Garage. Now It's Worth $225 Million.

Tom Humble, CXO and founder of E.C.D. Automotive Design, followed his passion for custom auto design into big business.

Business News

Actors From 'Lord of the Rings,' 'Breaking Bad' and More Were Tricked Into Creating Anti-Ukraine Messages on Cameo

The Microsoft Threat Analysis Center reports that pro-Russian propagandists used the popular platform Cameo to make celebrity videos that appear to be attacking Ukrainian president Volodymyr Zelensky.

Science & Technology

LITT Is Combining VR with Social Media, Fintech, and Ecommerce to Transform How We Interact with the World

It's and all-encompassing platform that aims to chart the future of digital interaction.